LCM
HCAT icon

Legato Capital Management’s Health Catalyst HCAT Stock Holding History

Legato Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-87,992
Closed -$622K – 596
2024
Q4 		$622K Buy
87,992
+3,171
+4% +$25.3K 0.08% 409
2024
Q3 		$690K Buy
+84,821
New +$613K 0.09% 381
2024
Q2 		– Sell
-97,133
Closed -$731K – 592
2024
Q1 		$731K Buy
+97,133
New +$887K 0.09% 348

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Legato Capital Management's HCAT Position: Q1 2025 in Review

Legato Capital Management sold out of Health Catalyst (HCAT) in Q1 2025, closing a stake of 87,992 shares — an estimated $622K sold.

Legato Capital Management first reported a position in HCAT in Q1 2024 and held it in 3 quarters. The position peaked at $731K in Q1 2024. 165 funds tracked by Wall St. Rank hold HCAT as of Q1 2025.

  • Legato Capital Management reported no remaining Health Catalyst position as of Q1 2025 after selling out during the quarter.
  • Legato Capital Management sold 87,992 Health Catalyst shares in Q1 2025, an estimated $622K.
  • Legato Capital Management first reported a position in Health Catalyst in Q1 2024 and held it in 3 quarters.
  • Legato Capital Management's Health Catalyst position peaked at $731K in Q1 2024.
  • 165 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2025.

Based on Legato Capital Management's 13F filing for Q1 2025, filed 6 May 2025.